Assembly Biosciences Inc

ASMB · Moat type: REGULIERUNG

MoatScore

1/10

Fair Value

n/a

Margin of Safety

n/a

Rating

MEIDEN

GESCHÄFTSMODELL Assembly Biosciences is a clinical-stage biotechnology company that develops antiviral therapies against hepatitis B virus (HBV) and other infectious diseases and generates revenue primarily from licensing and collaboration agreements with major pharmaceutical companies.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.